Vitality Watch

Dossier pubmed preclinical 03-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Aging microenvironment induces CD8T cell exhaustion by suppressing hepatic β-hydroxybutyrylate synthesis.

Key claim: Aging suppresses hepatic BDH1-dependent β-hydroxybutyrate (3HB) synthesis, driving CD8 T-cell exhaustion via reduced PRKAR1B β-hydroxybutyrylation and CREM activation; 3HB supplementation restores aged antiviral, antitumor, and CAR-T immunity.

Abstract

The metabolic mechanisms by which aging blunts CD8T cell antitumor and pathogen defense remain unknown. We demonstrate that the aged microenvironment induces CD8T cell exhaustion by reducing β-hydroxybutyrate (3HB) bioavailability. Aging represses hepatic BDH1-dependent 3HB synthesis, restricting SLC16A1-mediated 3HB uptake. Hepatic BDH1 ablation recapitulates age-associated CD8T cell dysfunction, compromising antiviral and antitumor immunity, whereas 3HB supplementation reverses these deficits via protein β-hydroxybutyrylation. Using a 3HB-derived chemical probe, 3Halk, together with functional screening, we identify PRKAR1B as a primary effector of 3HB signaling. PRKAR1B β-hydroxybutyrylation inhibits the transcription factor cyclic AMP (cAMP)-responsive element modulator (CREM), which activates T cell exhaustion-related gene expression. Age-associated 3HB depletion enhances CREM-dependent transcription, sustaining CD8T cell exhaustion. Consistently, the aged microenvironment compromises chimeric antigen receptor (CAR) T antitumor activity, which is substantially restored by 3HB treatment. Collectively, this study uncovers a hepatic metabolism-derived 3HB-CREM axis governing CD8T cell immunosenescence, highlighting 3HB as a viable immunorestorative strategy to improve immunotherapy outcomes in aged individuals.

Why this matters

Aging CD8 T-cell exhaustion has been attributed mainly to cell-intrinsic programs and chronic antigen exposure; this work relocates part of the cause to a hepatic metabolic deficit — age-related loss of BDH1-dependent β-hydroxybutyrate synthesis — that feeds a specific lysine β-hydroxybutyrylation PTM on PRKAR1B in T cells. If it holds up beyond mice, it links ketogenic/fasting biology, hepatic aging, and T-cell immunotherapy failure (CAR-T, antitumor, antiviral) through a single metabolite, and nominates 3HB supplementation as a candidate adjunct to immune-based therapies in older patients.

Source

Link

Briefing card

Aging microenvironment induces CD8T cell exhaustion by suppressing hepatic β-hydroxybutyrylate synthesis.
Stage: preclinical · pubmed · 03-sep-2026

Applies to preclinical research on aged immunity and CAR-T in older recipients; no human protocol is implied.

Aging suppresses hepatic BDH1-dependent β-hydroxybutyrate (3HB) synthesis, driving CD8 T-cell exhaustion via reduced PRKAR1B β-hydroxybutyrylation and CREM activation; 3HB supplementation restores aged antiviral, antitumor, and CAR-T immunity.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.cmet.2026.08.009

build build 880 · 2bcef25 · 2026-11-18